You are here

  • Home
  • Archive
  • Volume 27, Issue 9
  • The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC–IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study

Citation Tools

Article menu
Download PDFPDF
Ovarian Cancer
The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC–IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Bogani G, Matteucci L, Tamberi S, et al
The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC–IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study
International Journal of Gynecologic Cancer 2017;27:1856-1862.